EcoDrugPlus

Ribosomal Protein L18

Ensembl ID : ENSLOCG00000000017
Gene Symbol: RPL18
3 Cross references
381 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSLOCG00000016509
Gene Symbol: RPL18A
3 Cross references
370 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSLOCG00000012805
Gene Symbol: RPL19
3 Cross references
377 Possible Orthologues:

Ribosomal Protein L21

Ensembl ID : ENSLOCG00000004171
Gene Symbol: RPL21
3 Cross references
784 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSLOCG00000004916
Gene Symbol: RPL22
3 Cross references
266 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSLOCG00000013711
Gene Symbol: RPL23
3 Cross references
230 Possible Orthologues:

Ribosomal Protein L23a

Ensembl ID : ENSLOCG00000005815
Gene Symbol: RPL23A
3 Cross references
210 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSLOCG00000009548
Gene Symbol: RPL24
3 Cross references
322 Possible Orthologues:

Ribosomal Protein L26 Like 1

Ensembl ID : ENSLOCG00000009189
Gene Symbol: RPL26L1
3 Cross references
477 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSLOCG00000012239
Gene Symbol: RPL27
3 Cross references
370 Possible Orthologues:

Ribosomal Protein L27a

Ensembl ID : ENSLOCG00000003356
Gene Symbol: RPL27A
4 Cross references
516 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSLOCG00000003073
Gene Symbol: RPL28
3 Cross references
285 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).